OFFICIAL PUBLICATION OF

by its subsidiary APPco

Getting updated

28/08/2019

PI documents for DOACs in Australia are being updated to include new information about increased risk of recurrent thrombotic events in a specific group of patients Pharmacists are advised that Product Information (PI) documents for direct acting oral anticoagulants (DOACs) registered in Australia are being updated to include new information about increased risk of recurrent

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Getting updated

Previous ‘Crazy, but that’s the law.’

Next Vale John Matthews

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous ‘Crazy, but that’s the law.’

Next Vale John Matthews

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.